NCT02164045
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site San Antonio, Texas, United States
Clinical trial condition
Slow Virus Diseases
Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.
2,616 public trials
184 recruiting studies
Slow Virus Diseases trial results
NCT02638493
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- University of North Carolina Chapel Hill, North Carolina, United States
NCT00723775
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
Completed
Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors
NCT00543101
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- Spectrum Medical Group Phoenix, Arizona, United States
- AIDS Healthcare Foundation Los Angeles, California, United States
- Orlando Immunology Center Orlando, Florida, United States
- Community Research Initiative of New England Boston, Massachusetts, United States
NCT02805556
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Lisburn, United Kingdom
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Spectrum Medical Group Phoenix, Arizona, United States
- AIDS Healthcare Foundation Los Angeles, California, United States
- Denver Public Health Denver, Colorado, United States
- Whitman-Walker Clinic Washington D.C., District of Columbia, United States
Completed
Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
NCT01516970
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
- Locations
-
- Berlin, Germany
- Bonn, Germany
- Cologne, Germany
- Dortmund, Germany
NCT00641888
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- University of California, Davis Sacramento, California, United States
Completed
Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients
NCT00001650
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials
NCT00394004
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States